We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
What's new in cell therapies in ARDS?
- Authors
Horie, Shahd; Curley, Gerard; Laffey, John; Curley, Gerard F; Laffey, John G
- Abstract
The article reports on cell therapies in acute respiratory distress syndrome (ARDS). It mentions that the disease is considered destructive with a mortality rate of 40% which fortunately reduced by utilizing lung-protective ventilation. An overview of mesenchymal stem/stromal cells (MSCs) and human-induced pluripotent stem (iPS) cells.
- Subjects
ADULT respiratory distress syndrome treatment; MESENCHYMAL stem cells; INDUCED pluripotent stem cells; ARTIFICIAL respiration; MORTALITY
- Publication
Intensive Care Medicine, 2016, Vol 42, Issue 5, p779
- ISSN
0342-4642
- Publication type
journal article
- DOI
10.1007/s00134-015-4140-3